Study of some hormones and Partial purification of prolidase from serum of women with polycystic ovary syndrome
Article Sidebar
Main Article Content
Abstract
This study was done by partially purification of prolidase from serum of patients with polycystic ovary syndrome by Gel filtration technique, and using sephadex G100 gel as a stationary phase. The degree of purification (15.1) fold, enzyme yield (95.5%) and specific activity (0.00176 IU/I), were carried out .Kinetics studies for the partial purified enzyme technique showed optimal concentration of substrate which was 5 mmol/l Km = 0.66ng and Vmax =0.80 mM, while optimum Temperature was (35C°) and optimum pH was (8). The molecular weight of the partial purified enzyme has been determined by gel electrophoresis method , in presence of polyacrylamide gel and sodium dodecyl sulphate (SDS_PAGE) which showed that the approximates molecular weight was (54KD),we found high level of prolactin in the patient with polycystic ovary syndrome which was(24.03) when in the control was( 10.09),the value of TSH in the patient was( 17.08) which is high value and in the control was( 1.49), the value of T4 in the patient was (100.2) and in control was (118.4),the value of T3 in the patient was (0.3)and in control was (1.3).Testosterone in patient was (0.391) and in control was (0.206).
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Kollmann, M., Martins, W. P., & Raine-Fenning, N. (2014). Terms and thresholds for the ultrasound evaluation of the ovaries in women with hyperandrogenic anovulation. Human reproduction update, 20(3), 463-464.
[2] Draft Summary and Recommendations of International Evidenced-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. [(accessed on 28 October 2018)];2018 Available online. [3] “International evidence-based guideline for the assessment and management of polycystic ovary syndrome,” Accessed, 2018.
[4] Londe P, Shubhi Agarwal (2017) Invitro phytochemical study on Berberis aristata root extracts: An effective neutraceutical for the treatment of polycystic ovarian syndrome. International Journal of Recent Scientific Research 8(9): 19934-19940. [5] McCartney CR, Marshall JC: Polycystic Ovary Syndrome. N Engl J Med 2016;375:54-64. [6] Varghese, J., Kantharaju, S., Thunga, S., Joseph, N., & Singh, P. K. (2015). Prevalence and predictors of metabolic syndrome in women with polycystic ovarian syndrome: a study from Southern India. Int J Reprod Contracept Obstet Gynecol, 4(1), 113-118.
[7] Wilk, P., Uehlein, M., Kalms, J., Dobbek, H., Mueller, U., & Weiss, M. S. (2017). Substrate specificity and reaction mechanism of human prolidase. The FEBS journal, 284(17), 2870-2885. . [8] Draft Summary and Recommendations of International Evidenced-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. [(accessed on 28 October 2018)];2018 Available online.. [9] Gibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A. (2016). Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 102(2), 604-612.
[10] Teede, H., Gibson-Helm, M., Norman, R. J., & Boyle, J. (2014). Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. The Journal of Clinical Endocrinology & Metabolism, 99(1), E107-E111.
[11] Namiduru ES. Prolidase. Bratisl Lek Listy. 2016;117(8):480-5. PubMed PMID:
27546702. [12]- Klar, A., Navon-Elkan, P., Rubinow, A., Branski, D., Hurvitz, H., Christensen, E., ... & Falik-Zaccai, T. C. (2010). Prolidase deficiency: it looks like systemic lupus erythematosus but it is not. European journal of pediatrics, 169(6), 727-732.
[13] Pirinççi, N., Kaba, M., Geçit, İ., Güneş, M., Yüksel, M. B., Tanık, S., ... & Demir, H. (2016). Serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with renal cell carcinoma. Toxicology and industrial health, 32(2), 193-199. .
[14] Vilgio , S., Annovazzi,L., Conti, B., Genta , L., Perugini ,P., zanone ,C., casado ,B., cetta, G. et al . (2006) the role of emerging techiques in the investigation of prolidas deficiency: From diagnosis to the development of apossible therapeutical approach . Chromatogar a analyt Technol. Biomed life SCI 832, 1-8 .
[15] Courtin ,P., Nardi ,M., Wegmann.U., Joutsjoki , V., ogier, J.c., Gripon, J.c., Plava ,A., Henrich , B . et al . (2002) Accerlerating Cheese proteolysis by enriching lactococcus lactis proteolytic system with lactobacill : peptidases . Int Dairy J 12.447-454.
[16] Falkner W.R. and Meites S.(1982), selected Method of clinical chemistry. AACC. Washington, D.C.9:p319. [17] Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. (2011). Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 96(2), 273-288.
[18] Krassas, GE; Poppe, K; Glinoer (2010) Thyroid function and human reproductive health . Endocr . Rev. 2010 31:702-755.
[19] Cloud-Colne Corps (2017). Enzyme Linked Immunosorbent assay Kit for prolidas . Guide12th edn. SE234 Hu, Katy, Tx 77494,USA [20] Wilk, P., Uehlein, M., Kalms, J., Dobbek, H., Mueller, U., & Weiss, M. S. (2017). Substrate specificity and reaction mechanism of human prolidase. The FEBS journal, 284(17), 2870-2885.
[21] Wang, H., Sun, M., Qin, Y., Xia, T., Ma, J., & Chen, Z. J. (2013). Mutations in DMC1 are not responsible for premature ovarian failure in Chinese women. Reproductive biomedicine online, 26(2), 175-178.
[22] Krassas, GE; Poppe, K; Gliinoer D (2010) Thyroid function and human reproductive health. Endocr. Rev. 2010 31:702-755.
[23] Ehramann, D. A.; Liljenquist, D. R.; Kasza, K.; K.; Azziz, R.; Legro, R.S.&Ghazzi, M. N. (2006) : Prevalence and Predictors of the metabolic syndrome in women with polycystic ovary syndrome . J. Clin. Endocrin. Metab.; jan; 91(1); 48-53. [24] Nielsen, M. E., Rasmussen, I. A., Kristensen, S. G., Christensen, S. T., Møllgård, K., Wreford Andersen, E., ... & Yding Andersen, C. (2010). In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Molecular human reproduction, 17(1), 63-70.
[25] Sen, A., Prizant, H., Light, A., Biswas, A., Hayes, E., Lee, H. J., & Hammes, S. R. (2014). Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor
and microRNA-125b expression. Proceedings of the National Academy of Sciences, 111(8), 3008-3013. [26] Vyas, N. K., Nickitenko, A., Rastogi, V. K., Shah, S. S., & Quiocho, F. A. (2010). Structural insights into the dual activities of the nerve agent degrading organophosphate anhydrolase/ prolidase. Biochemistry, 49(3), 547-559.
[27] Roy, S., & Kumar, V. (2014). A practical approach on SDS PAGE for separation of protein. Int. J. Sci. Res, 3(8), 955-960.